♫musicjinni

How Patients Benefit from Medical Cannabis - Bonni Goldstein

video thumbnail
ADD, ADHD, Anxiety, Autism, Epilepsy, Cannabinoids, Chronic Pain, Pediatrics

Bonni Goldstein presents "How Patients Benefit from Medical Cannabis" at CannMed 2017. Join us for CannMed 2018, taking place October 22-24, 2018 at the brand-new UCLA Luskin Conference Center. This industry-leading event will feature 7 expert panels and 31 presentations from Raphael Mechoulam, Ethan Russo, Bonni Goldstein, Dustin Sulak, Kevin McKernan, Staci Gruber, David Meiri, Jeff Chen and more. Learn more at www.cannmedevents.com.

How Patients Benefit from Medical Cannabis - Bonni Goldstein

How to Legally Recommend Cannabis to your Patients - Valerio Romano, Michael Cutler, Bonni Goldstein

Coffee Talk 4 with Bonni Goldstein, MD

Cannabis Used in Research Does Not Reflect Legal Markets - Nolan Kane

Hydrogenated Cannabis Oil - Mark Scialdone

CannMed 2019 - Connecting the Greatest Minds in Cannabis

CannMed 2018 to Showcase Greatest Minds in Cannabis Research

Cannabis for Pain Management and Opioid Use Reduction - Jordan Tishler

Using Cannabis as an Antineoplastic Agent: Exploring Strategies to Improve Clinical Outcomes

Jonathan Page - Elucidating Cannabinoid Biosynthesis Using Trichome Targeted Genomics | CannMed 2017

Matching an effective cannabis strain extract for a specific subtype of cancer - David Meiri

CannMed 2019 keynote Dr. David Meiri promotes the value of cannabis science conferences

It’s Not Easy Being Green... - Staci Gruber

The Endocannabinoid System – A Source for Drug Discovery - Alexandros Makriyannis

Automated Workflows for the Cannabis Analytical Lab... - Ryan M.Ravenelle

Assertions v. Evidence, Kindly Check Your Assertions at the Door - Jeffrey Hengenrather

Israel, Leading a Process: From Illegal Substance to Potent Medication - Michael Dor

Potential clinical benefits of CBD enriched extracts over purified CBD... - Fabricio Pamplona

Cannabis Contaminants: Practical Considerations vs. Regulatory Requirements - Christopher Hudalla

Open Source CNS and the Decentralization of Cannabis Genomics - Kevin McKernan

Cannabis Therapeutic Use in the Elderly - Debra Malka

Raphael Mechoulam Previews CannMed 2019 Keynote Presentation

A Personal Story - Amir Golan

Comparison of the Anti-Tumor Efficacy of a Whole-Plant Extract vs. Pure THC... - Mara Gordon

CannMed 2016 - Dr. Raphael Mechoulam on Moving Cannabis Research from the Lab to the Clinic

Cannabinoids as Antitumor Agents: Moving Toward the Clinic - Sean Mcallister

Endocannabinoid System: A Fifty Year Trip - Raphael Mechoulam

The Making of the World's First Autism and Cannabis Trial

A Clinician’s Approach to Managing Uncertainty in Medically Refractory Patients - John Gaitanis

Seth Crawford Announces Oregon CBD's Move into the Cannabis Market at CannMed 2022

Disclaimer DMCA